Commentary article

Beauty Is Being Redefined

When I first stepped into the nutricosmetics space, I was not sure it was where I belonged. The beauty industry’s dominant language; conceal, correct, defy aging, felt distant from my interest in holistic wellness. But through many years in this space, I was fortunate to discover the real depth of this category and to take part in a genuine shift: from “anti-aging” to aging beautifully. From focusing on external beauty and masking imperfections toward a holistic view of beauty as wellness that radiates outward. At the very foundation of this shift is the understanding that our emotional makeup shows on our skin far more than any makeup we put on.

In 2026, the intersection of beauty and longevity is closer than ever. The conversation around healthspan is shaping entire categories, and skin longevity is no longer just a cosmetic goal — it is increasingly understood as a biomarker of internal health. Skin is not a canvas to be decorated. It is a barometer.
A visible expression of everything happening beneath the surface. When we look in the mirror, it is rarely just skin we are seeing — it is our inflammation levels, our sleep debt, our nutritional status, and our hormonal rhythms.

Over the past months, I had the privilege of gathering perspectives from more than thirty contributors: scientists, clinicians, brand leaders, market researchers, and regulatory specialists from across the globe. One thing emerges clearly from their responses: even in the age of AI — and perhaps because of it — the future of beauty is more human. From greater inclusivity in science and product development to methodologies that close long-standing data gaps, we are moving toward a future that is more personalized while maintaining a holistic point of view

From Anti-Aging to Skin Longevity: A Vocabulary Change That Means Everything

The most universal observation across every single response: the era of “anti-aging” is giving way to a new vocabulary: skin longevity, resilience, healthy aging, healthspan. The language itself signals the philosophical shift. Anti-aging was a war metaphor; it framed time as the enemy and aging as defeat. The new framing is closer to stewardship. It calls for embracing aging and practicing self-love. Claims are around supporting the skin’s ability to maintain function and vitality as life unfolds, and embracing beauty as a long-term expression of inner balance. One contributor described it precisely: the question is no longer only what makes skin look better, the better question is which internal systems shape the way beauty is expressed.

Central to this reorientation is the gut-skin axis. The connection between gut microbiome composition, intestinal barrier integrity, and systemic inflammation has moved from hypothesis to a key mechanism. Postbiotics, fermented ingredients, and clinically validated probiotic strains are migrating from digestive health into beauty formulations. This extends further into the gut-brain-skin axis: the triangular relationship between the microbiome, the nervous system, and visible skin outcomes. Stress and poor sleep do not merely make us feel worse. They show up on the face. And this, perhaps more than any ingredient innovation, is what holistic beauty actually means when it is practiced rather than just marketed.

The GLP-1 Moment: Opportunity and Its Obligations

If the gut-skin axis is the enduring scientific narrative of this moment, the rise of GLP-1 receptor agonists is the most disruptive contemporary story. Approximately seventeen percent of global consumers are now using GLP-1 medications in some capacity. The aesthetic implications are real: rapid weight loss leads to skin laxity, facial volume loss, and hair shedding — giving rise to the “Ozempic face” conversation and driving demand for targeted solutions in collagen support, tissue repair, alongside hair and scalp health. A category already gaining momentum, now accelerated further. And particularly the “skinification” of hair was repeatedly mentioned.

What is less discussed — and what struck me as one of the most important signals in these pages — is the regulatory complexity that accompanies this opportunity. In April 2026, the Dutch Keuringsraad explicitly stated that identifying GLP-1 users as a distinct target demographic for food supplements is not currently permitted in Europe. The UK ASA upheld a similar ruling the following month. The window is real, but it requires positioning grounded in authorized claim language.

Beauty meets real life: The Human, and the woman dimensions

With the focus on holistic beauty comes the recognition that sleep stress and cortisol management belong in the beauty conversation as much as they do in the stress and mood category. The emergence of neuro-beauty reflects something the industry is beginning to take seriously: that how you feel is inseparable from how you look.

Nowhere is this more evident than in the women’s hormonal journey. While the women’s health segment is growing, a truly nuanced approach to hormonal fluctuation and its impact on skin is still in its infancy. How skin changes across the menstrual cycle, the volatility of perimenopause, the distinct biology of post-menopause, I believe these distinctions matter more than the industry has acknowledged. Perimenopause is not a smooth, gradual estrogen decline. It is volatile: surges and crashes can occur within the same week, with the skin constantly recalibrating to a moving target. This topic is entirely absent from the clinical and the marketing conversations.

The recent removal of the black-box warning on Hormone Replacement Therapy (HRT) is actively changing the landscape, with more women now on hormone therapy — a variable that has direct implications on skin and should be addressed in both formulation and clinical designs. Coupled with the growing understanding of how hormonal balance affects mood, sleep, and cellular repair, there is real room for tailored innovation at the intersection of beauty, sleep, and hormonal health. The industry’s tendency to build a single “menopause solution” is a placeholder — waiting to be replaced by something more nuanced and accurate.

From Pill to Ritual: Delivery Innovation as Adherence Technology

One of the most consistent themes was the experiential gap between topical and ingestible beauty — and the urgency of closing it. Topical skincare has spent decades perfecting the ritual: the texture, the layering, the scent, the morning and evening moments of self-care. Ingestible beauty has historically lived in medicine cabinets, not on vanity shelves. That is changing — but it requires rethinking beauty from within not as a product to take, but as a ritual to build.

As one expert put it: a product that does not delight will not become a daily habit. Because even a product with a full clinically validated dose does nothing if it stays on the shelf. Contributors described the best ingestible formats as delivering a sophisticated interplay of flavor, texture, and fragrance — a micro moment of wellness that earns its place in a self-care routine. Consistency, not just efficacy, is what drives visible results over time.

K-Beauty’s influence is visible not only in ingredients but in formats. Functional beverages are expanding into matcha drinks, collagen-infused waters, and more. Effervescent formats, better-for-you gummies, sublingual drops, drinkable gels, and even freeze-dried fruit as a delivery matrix are moving beauty nutrition from the supplement aisle to the kitchen counter and the morning ritual.

The formulation challenge remains real — collagen at effective doses strains texture; botanical extracts bring bitterness; lipid-soluble actives present stability hurdles. But these constraints are drivers of meaningful innovation. The brands that navigate this well will not simply have good formulas. They will have made something consumers reach for — which is the only path to the long-term results that both brands and consumers need.

The Credibility Imperative

Across all responses, one expectation was clear: clinical substantiation is no longer optional. It is the entry ticket. Today’s consumers ask not just what an ingredient does, but at what dose, in which population, measured by which endpoint, over what duration. Answering this precisely is no longer a marketing upgrade. It is a well-needed standard.

But rigor alone is not enough. That evidence must also reflect the full diversity of people this category claims to serve. Clinical dermatology has historically suffered from a profound homogeneity bias — trials conducted predominantly on lighter skin tones, rarely enrolling participants over sixty-five, with the skin biology of many real consumers simply absent from the data. As one contributor put it, the category’s most significant scientific blind spots are advanced age and genuine demographic diversity. Decentralized clinical trial methods — enabling broader geographic and demographic recruitment, remote data collection, and longitudinal tracking across life stages — are emerging as one of the most promising tools for closing this gap. If the science is to lead, it must look like the people it is for.

A New Definition, Not a New Trend

The contributors gathered in this issue do not represent the next trend in beauty. They represent something more consequential: the emergence of a new definition.

Beauty is becoming a language for systemic health. Skin that reflects inner balance, not inner perfection. Formulations built around biological logic, not marketing narratives. Delivery systems designed to become rituals, not obligations. Claims connected to the physiological mechanisms that produce them. The same inside-out logic is already expanding into scalp and hair health — the territory of beauty from within is growing in ways that were not imaginable a decade ago.

In Appreciation

The insights shared by this diverse group of experts from across the globe, paint a picture of a category at a genuine inflection point: more scientifically grounded, more inclusive, and more honest about its gaps, opportunities, and blind spots.

I am deeply grateful for the generosity and depth of this conversation, and for the opportunity to help probe the edges of what this category is becoming. Most of all- I am thankful for the opportunity to play a part in inspiring future innovation at the intersection of beauty and wellness.

–

Panelists

Vincenzo Zaccaria
Bionap (Active Group)

Trisha Sugarek MacDonald
Akay Bioactives, an Oterra company

Benny Antony
Arjuna Natural

Carlos Morales Ruiz
Aurora Intelligent Nutrition

Juliane Hellhammer, Franziska Schmitt
DAACRO

Annie Liu, KG Rao, Zachin Rao
DolCas Biotech

Miri Eliyahu, Magda Starula
Euromonitor International

Aarthi Janakiraman
Everest Group

Dieter Bracke
Fermedics BV

Mike Hughes
FMCG Gurus

Katia Merten-Lentz
Food Law Science and Partners

Oliver Wolf
Gelita

Silvia Pisoni
Gnosis by Lesaffre

David Foreman
Herbal Pharmacist Media

Lucilla Caricchio
Hylobates Consulting

Johanna Maukonen, Arthur C. Ouwehand
IFF Health

Serena Tongiani
Indena

Volker Spitzer, Stephanie Krammer-Lukas
IQVIA Consumer Health

Tyler Holstein
Kemin Human Nutrition and Health

Alison M. Winger
Key2Biotics

Karen E. Todd
Kyowa Hakko

Celia Martin
Lallemand Bio-Ingredients

Elodie Aragon
Lallemand Health Solutions

Chris Kilham
Medicine Hunter

Greg Cumberford¹, Pauline Cox²
1. Natures Crops International
2. Sow & Arrow

Sybille Buchwald-Werner
Newday

Laetitia d’Ursel¹, Belinda Tan¹, Colleen Quinn²
1. People Science
2. Colleen Quinn Consultancy

Matevž Ambrožič, Maja Orešnik
PharmaLinea

Lucia Barra, Annalisa Visciglia
Probiotical

Walter Fiore
ROELMI HPC

Florencia Moreno Torres
Rousselot

Shaheen Majeed
Sabinsa

Ilaria Campestri
B2B Health & Beauty, ESG Industrial Processes Expert

Kelly Dobos
Consultant, Cosmetic Chemist

He Li
School of Food & Health Beijing Technology & Business University

Claire Liu
Seppic

Suyin Perret-Gentil Robespierre
Suannutra

Jennifer Toomey, Inbal Nahmias
TopGum Industries

Anu Turpeinen
Valio

Discover the complete panel discussion, including expert insights and key takeaways, in the digital edition.